Randomized trial · people

Pramlintide-insulin loop: time in range held without carb counting

Checked against the paper Randomized trialPublished by PepVault

The takeaway

Early evidence suggests that adding pramlintide to an automated insulin system may let people with type 1 diabetes skip carb counting without losing time in range, but the trial was too small and short to settle it.

Kind
Randomized trial
Studied in
People
Number studied
12
Published
2025
Journal
J Diabetes Sci Technol

What they tested

Could an automated system that delivers both insulin and pramlintide control blood sugar in type 1 diabetes without people counting the carbohydrates in their meals?

How the study was done

A small pilot randomized, controlled trial in 12 adults with type 1 diabetes. Each person went through 5 arms of 14 hours each, outpatient and supervised in daily life: faster aspart insulin with carb counting (the control), or a fully closed-loop system (one that doses automatically) giving faster aspart or aspart with pramlintide at 8 µg/U or 10 µg/U ratios, with no carb counting.

A woman in glasses at a kitchen table with a laptop, a mug and her phone

PepVault for iPhone

Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

What they found

Median time in the target range of 3.9-10.0 mmol/L was 78.6 in the carb-counting control arm. With the closed-loop faster aspart and pramlintide system it was 76.2 at the 8 µg/U ratio and 78.8 at the 10 µg/U ratio; with aspart and pramlintide it was 65.9 at 8 µg/U and 77.4 at 10 µg/U. Time spent below 3.9 and 3.0 mmol/L, meaning low blood sugar, was numerically higher in the aspart and pramlintide arms than in the control arm. None of these differences were statistically significant.

What it doesn’t show

This was a pilot trial in only 12 adults, with each setup tested for just 14 hours, so it cannot show how the system performs over weeks or months. The authors say a longer and larger study is underway.

The paper

Odabassian et al. A Pilot Outpatient Assessment of a Fully Closed-Loop Insulin and Pramlintide System. J Diabetes Sci Technol. 2025.

The compound

More studies on Pramlintide

Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.

Track it in the app

PepVault for iPhone

Taking pramlintide? Keep your own record

Log each dose, your weight and how you feel, in one place.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo